9.78 USD
↘ 0.16 (1.66%)PRE MARKET (AS OF 07:16 AM EST)
Shares of Climb Bio, Inc. Common Stock (CLYM) are trading at $9.78. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, CLYM appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.